Inventor · disambiguated record
Guang Qu
Also filed as: QU GUANG
13 granted patents·13 pending applications·380 citations·filing 2004–2022
92Inventor score
Files withGENZYME CORP8SPARK THERAPEUTICS INC7CHILDRENS HOSPITAL PHILADELPHIA5PHILADELPHIA CHILDREN HOSPITAL2QU GUANG2
Top patents by PatentIndex Score
26 records- 0197US8137948B2Methods for producing preparations of recombinant AAV virions substantially free of empty capsidsQU GUANG·Filed 2007·Granted Mar 20, 2012·181 cites·8 claims
- 0297US7704721B2Compositions and methods to prevent AAV vector aggregationGENZYME CORP·Filed 2005·Granted Apr 27, 2010·74 cites·11 claims
- 0396US9051542B2Compositions and methods to prevent AAV vector aggregationWRIGHT JOHN FRASER·Filed 2010·Granted Jun 9, 2015·49 cites·6 claims
- 0495US9528126B2Methods for producing preparations of recombinant AAV virions substantially free of empty capsidsQU GUANG·Filed 2012·Granted Dec 27, 2016·37 cites·11 claims
- 0592US9408904B2Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapyWRIGHT JOHN FRASER·Filed 2012·Granted Aug 9, 2016·22 cites·21 claims
- 0691US11261463B2Methods for producing preparations of recombinant AAV virions substantially free of empty capsidsGENZYME CORP·Filed 2019·Granted Mar 1, 2022·3 cites·10 claims
- 0788US7261544B2Methods for producing preparations of recombinant AAV virions substantially free of empty capsidsGENZYME CORP·Filed 2004·Granted Aug 28, 2007·13 cites·14 claims
- 0881US10994028B2Scalable manufacturing process to produce recombinant lentiviral vectors in serum-free suspension cell culture systemCHILDRENS HOSPITAL PHILADELPHIA·Filed 2017·Granted May 4, 2021·1 cites·38 claims
- 0980US2022364111A1Methods for producing preparations of recombinant aav virions substantially free of empty capsidsGENZYME CORP·Filed 2022·Application pending·0 cites
- 1070US11878056B2Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapyCHILDRENS HOSPITAL PHILADELPHIA·Filed 2020·Granted Jan 23, 2024·0 cites·24 claims
- 1170US2019032081A1Methods for producing preparations of recombinant aav virions substantially free of empty capsidsGENZYME CORP·Filed 2018·Application pending·0 cites
- 1266US2017260545A1Methods for producing preparations of recombinant aav virions substantially free of empty capsidsGENZYME CORP·Filed 2016·Application pending·0 cites
- 1362US2017247664A1Compositions and methods to prevent aav vector aggregationGENZYME CORP·Filed 2016·Application pending·0 cites
- 1462US2014323556A1Scalable manufacturing process to produce recombinant lentiviral vectors in serum-free suspension cell culture systemPHILADELPHIA CHILDREN HOSPITAL·Filed 2014·Application pending·0 cites
- 1561US2019321463A1Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapyCHILDRENS HOSPITAL PHILADELPHIA·Filed 2019·Application pending·0 cites
- 1660US11807865B2Large commercial scale lentiviral vector production system and vectors produced therebyCHILDRENS HOSPITAL PHILADELPHIA·Filed 2018·Granted Nov 7, 2023·0 cites·18 claims
- 1759US2016083694A1Compositions and methods to prevent aav vector aggregationGENZYME CORP·Filed 2015·Application pending·0 cites
- 1855US10328145B2Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapyCHILDRENS HOSPITAL PHILADELPHIA·Filed 2016·Granted Jun 25, 2019·0 cites·24 claims
- 1948US2022025396A1Plasmid free aav vector producing cell linesSPARK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2046US2021079422A1Aav vector column purification methodsSPARK THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2144US2014349403A1Large commercial scale lentiviral vector production system and vectors produced therebyPHILADELPHIA CHILDREN HOSPITAL·Filed 2012·Application pending·0 cites
- 2243US12404526B2Enhancing agents for improved cell transfection and/or rAAV vector productionSPARK THERAPEUTICS INC·Filed 2018·Granted Sep 2, 2025·0 cites·37 claims
- 2342US11702639B2Column-based fully scalable rAAV manufacturing processSPARK THERAPEUTICS INC·Filed 2017·Granted Jul 18, 2023·0 cites·47 claims
- 2442US2019284576A1SCALABLE HIGH RECOVERY METHODS FOR PRODUCING HIGH YIELD RECOMBINANT ADENO-ASSOCIATED VIRAL (rAAV) VECTOR AND RECOMBINANT ADENO-ASSOCIATED VIRAL (rAAV) VECTORS PRODUCED THEREBYSPARK THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2541US2019292561A1Scalable methods for producing recombinant adeno-associated viral (aav) vector in serum-free suspension cell culture system suitable for clinical useSPARK THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2638US2019078099A1Cell line for recombinant protein and/or viral vector productionSPARK THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guang Qu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →